KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review
出版年份 2016 全文链接
标题
KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review
作者
关键词
Pancreatic cancer, Mutation, KRAS, BRAF, PIK3CA
出版物
MEDICAL ONCOLOGY
Volume 33, Issue 4, Pages -
出版商
Springer Nature
发表日期
2016-02-29
DOI
10.1007/s12032-016-0745-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- KRAS Mutations in Codon 12 or 13 Are Associated With Worse Prognosis in Pancreatic Ductal Adenocarcinoma
- (2014) Bruno V. Sinn et al. PANCREAS
- Reporting Tumor Molecular Heterogeneity in Histopathological Diagnosis
- (2014) Andrea Mafficini et al. PLoS One
- KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas
- (2013) Alyssa M Krasinskas et al. MODERN PATHOLOGY
- Prognostic Value of BRAF V600 Mutations in Melanoma Patients After Resection of Metastatic Lymph Nodes
- (2012) Stéphanie Moreau et al. ANNALS OF SURGICAL ONCOLOGY
- Targeting Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer – from Molecular Signalling to Clinical Trials
- (2012) Marco Falasca et al. Anti-Cancer Agents in Medicinal Chemistry
- BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
- (2012) Rachel N. Grisham et al. CANCER
- Specific Mutations in KRAS Codons 12 and 13, and Patient Prognosis in 1075 BRAF Wild-Type Colorectal Cancers
- (2012) Y. Imamura et al. CLINICAL CANCER RESEARCH
- Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
- (2012) Shanxiang Shen et al. Diagnostic Pathology
- Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer
- (2012) Takeshi Ogura et al. JOURNAL OF GASTROENTEROLOGY
- Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
- (2011) D. R. Borger et al. ONCOLOGIST
- EGFR and KRAS Mutational Analysis and Their Correlation to Survival in Pancreatic and Periampullary Cancer
- (2011) Melissa Oliveira-Cunha et al. PANCREAS
- PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers
- (2011) Filip Janku et al. PLoS One
- 7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction
- (2010) Thomas W. Rice et al. ANNALS OF SURGICAL ONCOLOGY
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines
- (2009) Paola Ulivi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Are RAS mutations predictive markers of resistance to standard chemotherapy?
- (2009) Yohann Loriot et al. Nature Reviews Clinical Oncology
- Resequencing Analysis of the Human Tyrosine Kinase Gene Family in Pancreatic Cancer
- (2009) Takashi Kubo et al. PANCREAS
- Coordinated Epidermal Growth Factor Receptor Pathway Gene Overexpression Predicts Epidermal Growth Factor Receptor Inhibitor Sensitivity in Pancreatic Cancer
- (2008) A. Jimeno et al. CANCER RESEARCH
- Akt as a therapeutic target in cancer
- (2008) Linda S Steelman et al. EXPERT OPINION ON THERAPEUTIC TARGETS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now